Subsequently, we analyzed the correlation between KCTDs gene expression level and clinicopathologic features, and we found that the expression of KCTD5 and KCTD21 was significantly higher in the lymph node metastasis group than in the normal group. This evidence concerns the gene KCTD5 and metastatic malignant neoplasm in the lymph nodes.